-
-
Small Molecule Drug Platforms
-
Chiral Catalysis Technology
-
Continuous Flow Technology
-
Fluorine Chemistry
-
Enzyme Catalysis
-
Photocatalysis
-
Solid-State Research
显示更多 -
-
Drug Product (DP) Platforms
-
Sustained and Controlled Release
-
Solubility Enhancement
-
Topical Formulation
-
Liquid Formulation
-
Softgels
-
Oral Fast Dissolving Technology
显示更多 -
-
Peptide Platforms
显示更多 -
Research Team
-
Jiuzhou Pharma has successfully completed the UN Global Compact's SDG Ambition Accelerator (2024)
Release time:
2025-01-17
In recent days, the United Nations Global Compact (UNGC) Liaison Office in China held the 2024-2025 Corporate Accelerator Program Annual Meeting in Beijing. Jiuzhou Pharma, as one of the participating companies, was awarded the completion certificate of the UNGC SDG Ambition Accelerator (2024).

The SDG Ambition Accelerator (SDGA) is a capability-building program lasting three to six months that aims to challenge and support members of the UNGC to set ambitious corporate goals and accelerate the integration of the 17 United Nations Sustainable Development Goals with core business management, creating long-term value for their business and the society in which they operate.
Jiuzhou Pharma attaches great importance to sustainable development. This year, the company's ESG executive committee initiated the "Sustainable Development Planning Project", requiring each business department to set five-year (2025-2030) ESG management goals based on global policy trends and customer ESG target setting, for the important issues identified by the company. The ESG Executive Committee has submitted a proposal for the "Key ESG Objectives of Jiuzhou Pharma" to the Board of Directors' Strategic Decision-making Committee and has been reviewed and approved. In addition, the company has also recently applied to join the "Science-Based Targets Initiative" (SBTi).
Other News
2026-11-10
Winter Process Chemistry Conference
2026-11-03
2026-11-03
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Established Business Services(API)
Tel: 86-576-88881561
E-mail: bd@jiuzhoupharma.com